Cite
HARVARD Citation
Wong, K. et al. (n.d.). 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment. Journal for immunotherapy of cancer. pp. A87-A88. [Online].